Your browser is no longer supported. Please, upgrade your browser.
Settings
AXGN AxoGen, Inc. daily Stock Chart
AXGN [NASD]
AxoGen, Inc.
Index- P/E- EPS (ttm)-0.47 Insider Own1.10% Shs Outstand32.36M Perf Week2.63%
Market Cap378.61M Forward P/E- EPS next Y-0.01 Insider Trans0.00% Shs Float31.83M Perf Month16.42%
Income-14.40M PEG- EPS next Q-0.10 Inst Own66.50% Short Float4.69% Perf Quarter15.84%
Sales41.10M P/S9.21 EPS this Y8.40% Inst Trans-0.02% Short Ratio10.21 Perf Half Y30.73%
Book/sh0.46 P/B25.43 EPS next Y96.00% ROA-40.50% Target Price12.88 Perf Year113.11%
Cash/sh0.93 P/C12.62 EPS next 5Y- ROE-243.70% 52W Range5.23 - 11.85 Perf YTD30.00%
Dividend- P/FCF- EPS past 5Y29.90% ROI- 52W High-1.27% Beta0.36
Dividend %- Quick Ratio3.50 Sales past 5Y53.30% Gross Margin84.30% 52W Low123.71% ATR0.38
Employees146 Current Ratio4.00 Sales Q/Q46.20% Oper. Margin-19.80% RSI (14)66.85 Volatility3.62% 3.56%
OptionableYes Debt/Eq1.63 EPS Q/Q-43.30% Profit Margin-35.10% Rel Volume3.35 Prev Close11.50
ShortableYes LT Debt/Eq1.36 EarningsMay 04 AMC Payout- Avg Volume146.18K Price11.70
Recom1.80 SMA207.95% SMA5011.36% SMA20027.67% Volume489,091 Change1.74%
Mar-06-17Initiated ROTH Capital Buy $14.50
Nov-22-16Upgrade Lake Street Hold → Buy $9 → $11
Nov-07-16Reiterated Wedbush Outperform $10 → $12
Nov-03-16Downgrade Lake Street Buy → Hold $9
Aug-04-16Reiterated Wedbush Outperform $9 → $10
May-14-14Initiated Dawson James Buy $5
Oct-31-13Reiterated Ladenburg Thalmann Buy $4.50 → $5.75
Apr-17-17 12:47PM  ETFs with exposure to AxoGen, Inc. : April 17, 2017 Capital Cube
Apr-14-17 07:00AM  AxoGen, Inc. to Report First Quarter 2017 Financial Results and Host Conference Call on Thursday, May 4, 2017 GlobeNewswire
Apr-11-17 07:12PM  Cramer Remix: Why a slew of IPOs might not be a good thin... CNBC Videos
Apr-07-17 08:30AM  AxoGen, Inc. Announces 2017 Annual Shareholders Meeting GlobeNewswire
Apr-05-17 04:22PM  ETFs with exposure to AxoGen, Inc. : April 5, 2017 Capital Cube
Apr-03-17 08:17AM  AxoGen, Inc. breached its 50 day moving average in a Bullish Manner : AXGN-US : April 3, 2017 Capital Cube
Mar-17-17 12:08PM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Capital Cube
Mar-10-17 01:43PM  AxoGen, Inc. :AXGN-US: Earnings Analysis: 2016 By the Numbers : March 10, 2017 Capital Cube
Mar-07-17 01:04PM  AXOGEN, INC. Financials
07:00AM  AxoGen, Inc. to Present at the Oppenheimer 27th Annual Healthcare Conference GlobeNewswire
Mar-06-17 09:27AM  AxoGen, Inc. breached its 50 day moving average in a Bearish Manner : AXGN-US : March 6, 2017 Capital Cube
08:23AM  Coverage initiated on AxoGen by ROTH Capital
Mar-02-17 08:00AM  AxoGen, Inc. to Present at Upcoming Investor Conferences GlobeNewswire
Mar-01-17 04:15PM  AXOGEN, INC. Files SEC form 10-K, Annual Report
Feb-22-17 04:44PM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:16PM  AxoGen reports 4Q loss Associated Press
04:01PM  AxoGen, Inc. Reports 2016 Fourth Quarter and Full Year Financial Results GlobeNewswire
Feb-08-17 07:00AM  AxoGen, Inc. to Report Fourth Quarter and 2016 Full Year Financial Results and Host Conference Call on Wednesday, February 22, 2017 GlobeNewswire
Jan-26-17 04:58PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Jan-18-17 09:30AM  Zacks.com featured highlights: AxoGen, MAG Silver, Triumph Bancorp, UCP and Yelp
Jan-09-17 07:31AM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +10.75%
07:00AM  AxoGen, Inc. Preannounces Estimated Fourth Quarter and Full Year 2016 Revenue GlobeNewswire
Jan-05-17 04:01PM  AxoGen Appoints Ivica Ducic Medical Director GlobeNewswire
Jan-03-17 05:06PM  AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers
07:00AM  AxoGen to Participate at AAHS ASPN ASRM Joint 2017 Annual Meeting GlobeNewswire
Dec-30-16 10:53AM  ETFs with exposure to AxoGen, Inc. : December 30, 2016
Dec-14-16 12:44PM  ETFs with exposure to AxoGen, Inc. : December 14, 2016
07:00AM  AxoGen, Inc. announces Avance® Nerve Graft Recipient to be honored on the Donate Life Tournament of Roses Parade Float GlobeNewswire
Dec-10-16 11:03AM  Hedge Funds Are Betting On AxoGen, Inc. (AXGN) at Insider Monkey
Nov-21-16 07:00AM  AxoGen, Inc. Announces Commercial Release and First Clinical Implant of Avive Soft Tissue Membrane GlobeNewswire
Nov-17-16 07:00AM  AxoGen, Inc. to Present at the 28th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-15-16 07:00AM  AxoGen, Inc. to Host Analyst and Investor Event on November 21, 2016 GlobeNewswire
Nov-07-16 12:07PM  ETFs with exposure to AxoGen, Inc. : November 7, 2016
Nov-04-16 11:31AM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016 -6.40%
Nov-02-16 06:19PM  AxoGen reports 3Q loss
04:17PM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:08PM  AXOGEN, INC. Files SEC form 10-Q, Quarterly Report
04:01PM  AxoGen, Inc. Reports Financial Results for Third Quarter 2016 GlobeNewswire
07:07AM  Q3 2016 AxoGen Inc Earnings Release - After Market Close
Oct-31-16 04:17PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agr
Oct-26-16 07:00AM  AxoGen, Inc. Announces the Refinancing of its Debt Facility GlobeNewswire
Oct-19-16 07:00AM  AxoGen, Inc. to Report Third Quarter Financial Results and Host Conference Call on Wednesday, November 2, 2016 GlobeNewswire
Oct-13-16 04:33PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E
04:05PM  AxoGen Announces Closing of Public Offering of Common Stock and Underwriters Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Oct-12-16 09:39AM  ETFs with exposure to AxoGen, Inc. : October 12, 2016
Oct-07-16 09:00AM  AxoGen Announces Pricing of Public Offering of Common Stock GlobeNewswire +11.04%
Oct-06-16 04:05PM  AxoGen Announces Proposed Public Offering of Common Stock GlobeNewswire
Sep-27-16 09:52AM  ETFs with exposure to AxoGen, Inc. : September 27, 2016
Sep-26-16 08:41AM  Allergan Gets FDA Approval for New Line of Breast Implants
Sep-19-16 09:02AM  AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
07:00AM  AxoGen, Inc. Appoints Amy Wendell to Board of Directors GlobeNewswire
Sep-15-16 07:00AM  AxoGen to Participate at 71st Annual American Society for Surgery of the Hand Meeting GlobeNewswire
Sep-12-16 10:13AM  2 Biotech Stocks that Turned $8,000 into over $250,000 at Motley Fool
07:00AM  AxoGen, Inc. to Participate at the American Association of Oral and Maxillofacial Surgeons 98th Annual Meeting GlobeNewswire
Sep-07-16 10:20AM  Allergan Takes Over RetroSense; Boosts Eye Care Pipeline
Aug-29-16 05:13PM  Your Complete Guide to the Generic Drug Industry
11:02AM  ETFs with exposure to AxoGen, Inc. : August 29, 2016
Aug-12-16 12:50PM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-11-16 07:00AM  AxoGen, Inc. to Present at Wedbush PacGrow Healthcare Conference 2016 GlobeNewswire +8.35%
Aug-03-16 07:31PM  AxoGen reports 2Q loss +7.32%
04:12PM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:10PM  AxoGen, Inc. Reports Financial Results for Second Quarter 2016 GlobeNewswire
07:07AM  Q2 2016 AxoGen Inc Earnings Release - After Market Close
Jul-29-16 01:15PM  ETFs with exposure to AxoGen, Inc. : July 29, 2016
Jul-20-16 07:00AM  AxoGen, Inc. to Report Second Quarter Financial Results and Host Conference Call on Wednesday, August 3, 2016 GlobeNewswire
Jul-11-16 04:32PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Jul-06-16 04:31PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Jun-27-16 07:00AM  AxoGen, Inc. Added to Russell 2000® Index GlobeNewswire
Jun-21-16 12:47PM  ETFs with exposure to AxoGen, Inc. : June 21, 2016
07:00AM  AxoGen, Inc.s Avance® Nerve Graft Data to be Presented at 2016 Federation of European Societies for Surgery of the Hand International Congress GlobeNewswire
Jun-16-16 07:00AM  AxoGen to Present at JMP Securities Healthcare Conference 2016 GlobeNewswire
May-31-16 04:41PM  AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Securi
May-26-16 07:14PM  ETFs with exposure to AxoGen, Inc. : May 26, 2016
May-13-16 10:21AM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q1, 2016 By the Numbers
May-04-16 07:12PM  AxoGen reports 1Q loss
04:21PM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:10PM  AxoGen, Inc. First Quarter Revenue Increases 64% Over Prior Year to $8.1 Million GlobeNewswire
04:09PM  AXOGEN, INC. Files SEC form 10-Q, Quarterly Report
07:07AM  Q1 2016 AxoGen Inc Earnings Release - After Market Close
Apr-29-16 09:52AM  AxoGen (AXGN) Enters Overbought Territory
Apr-20-16 07:24AM  AxoGen, Inc. to Report First Quarter Results GlobeNewswire
Apr-08-16 06:58AM  AxoGen, Inc. to Feature Nerve Repair Solutions at the American College of Oral and Maxillofacial Surgeons (ACOMS) Annual Scientific Conference and Exhibition GlobeNewswire
Mar-30-16 07:05AM  AxoGen, Inc. Launches AcroVal(TM) Neurosensory & Motor Testing System GlobeNewswire
Mar-18-16 03:55PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Mar-14-16 05:10PM  AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
07:21AM  Kevin Leach Appointed Vice President of Marketing of AxoGen, Inc. GlobeNewswire
Mar-09-16 07:09AM  AxoGen, Inc. to Participate at the 28th Annual ROTH Growth Conference GlobeNewswire
Mar-01-16 04:30PM  CFO Moves: Delphi Automotive, Hain Celestial Group, AxoGen Inc. at The Wall Street Journal
07:04AM  AxoGen Appoints Peter J. Mariani Chief Financial Officer GlobeNewswire
Feb-29-16 08:17PM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Offi
06:44PM  AXOGEN, INC. Files SEC form 10-K, Annual Report
06:31PM  AxoGen reports 4Q loss
04:18PM  AxoGen Inc. Reports Record Revenue Results GlobeNewswire
07:07AM  Q4 2015 AxoGen Inc Earnings Release - After Market Close
AxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The company's surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DeVinney Erick WayneVP, Clinical&Translational ScMar 14Option Exercise0.275,0181,3555,018Mar 14 07:32 PM
Donovan Michael PatrickVP OperationsMar 14Option Exercise1.559,65914,9589,659Mar 14 07:32 PM
Freitag Gregory GeneGeneral Counsel & SVP BDDec 30Option Exercise2.7423,00063,02071,901Mar 14 07:31 PM
Engels John PVPOct 07Buy7.504,00030,00098,425Oct 14 01:37 PM
Zaderej Karen L.CEOOct 07Buy7.5010,00075,000242,147Oct 14 01:37 PM
MARIANI PETER JChief Financial OfficerOct 07Buy7.503,33324,9983,333Oct 14 03:13 PM
Leach KevinVice President MarketingOct 07Buy7.502,00015,0002,000Oct 14 03:14 PM
Wendell Amy McBrideDirectorOct 07Buy7.5013,33399,99813,333Oct 14 03:36 PM
Gold Mark StephenDirectorAug 17Option Exercise3.603,75013,500325,248Aug 19 03:25 PM
Mandato Joseph MDirectorAug 09Sale8.3042,168349,9941,226,773Aug 10 07:28 PM
Mandato Joseph MDirectorAug 08Sale8.63107,450927,2941,268,941Aug 10 07:28 PM
Flynn James EPossible Member of 10% GroupJul 21Sale6.70102,136684,3113,000,000Jul 21 04:26 PM
Flynn James EPossible Member of 10% GroupJul 18Sale6.8741,425284,5903,102,136Jul 18 06:20 PM
Flynn James EPossible Member of 10% GroupJul 15Sale7.3231,788232,6883,143,561Jul 18 06:20 PM
Flynn James EPossible Member of 10% GroupJul 14Sale7.70206,0901,586,8933,175,349Jul 18 06:20 PM
Hansen David KChief Accounting OfficerMay 31Option Exercise0.279,8212,6529,821Jun 01 05:00 PM